Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Adenosine derivatives for cardiovascular, lipid disorders

March 30, 1998

Lilly evaluates cardiovascular effects of Evista in RUTH trial

March 27, 1998

Bosentan reduces blood pressure in patients with essential hypertension

March 26, 1998

VEGF gene medicine incorporating DOTMA enters phase II testing

March 25, 1998

Spotlight on dual-action ACE/NEP inhibitors

March 25, 1998

Calcium channel blockers do not increase risk of cancer in patients with coronary artery disease

March 24, 1998

U. of Alberta researchers discover novel 1,4-dihydropyridine calcium channel modulators

March 20, 1998

Vitamin C prevents development of nitrate tolerance in CHF

March 20, 1998

Mochida describes PDE V inhibitors for pulmonary hypertension, ischemic heart disease

March 20, 1998

CytRx begins patient enrollment for Flocor phase III trial

March 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...